Close Menu

Europe

The firm's technology uses ex vivo organ culture to model cancer growth and predict a patient's tumor response to chemotherapy and targeted drugs. 

The researchers covered 100 organisms from a wide range of taxonomies, allowing for large-scale cross comparisons of species at the protein level.

Investigators identified an inbred individual who appeared to be part of a high-status group buried in lavish tombs during the Neolithic period.

In Cell this week: catalog of structural variants within the human genome, proteomic and metabolomic profiles of COVID-19 patients' blood, and more.

The launch of the company's Prism system earlier this month should support the development of an accompanying menu of tests to serve diverse users.

The Rida Gene SARS-CoV-2 test runs on the Roche LightCycler 480II and is intended for use in hospital, reference, private, and state laboratories.

The company is providing DNA/RNA extraction kits, viral RNA isolation platforms, workstations, and kits for detecting nucleic acids from the coronavirus to the lab.

Next Steps to Take

New Scientist describes next steps supporters of the #ShutdownSTEM strike could take to combat racism in academia.

In PNAS this week: features linked to coronavirus pathogenicity, multi-system syndrome linked to RNA modification-linked mutations, and more.

Yourgene will provide molecular COVID-19 testing to corporate clients of Caxton, who will obtain their results through Hooha Innovations' Prova app.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.